Lion's Mane for Depression & Mood: The Evidence Review

By Peter Orpen, Co-Owner, Teelixir · Updated March 2026

Depression doesn't always look the way people expect. Sometimes it's not sadness — it's flatness. A foggy disconnection from things you once cared about. And when you start searching for natural support alongside professional treatment, you encounter a lot of noise and very little clarity.

Lion's mane mushroom (Hericium erinaceus) has quietly emerged in mood research for a reason most people don't expect. It's not because it acts like an antidepressant. It's because of something we call "The Neurotrophic Cascade Effect".

Most conversations about supplements and depression focus on serotonin. Lion's mane takes an entirely different route. Its bioactive compounds — hericenones from the fruiting body and erinacines from the mycelium — stimulate the production of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). These are proteins that support the growth, survival, and repair of neurons. Low BDNF levels are consistently associated with depression in clinical literature. Supporting these pathways is a fundamentally different approach to mood. Not suppressing symptoms. Supporting the biological infrastructure that mood depends on.

We call this "The Neurotrophic Cascade Effect": the possibility of building better neural connections through a cascade of upstream neurochemical support — not just managing a single downstream molecule like serotonin. It's a promising framework. But it's also still emerging research, and the honest picture includes significant limitations.

"The Neurotrophic Cascade Effect" — Why Lion's Mane Takes a Different Route

To understand why lion's mane is interesting for depression research, you need to understand one concept: neurotrophins — and what researchers call "The BDNF-Depression Gap".

Neurotrophins are proteins that act as fertiliser for the brain. They signal neurons to grow, branch, and connect. The most studied are nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). Both play critical roles in mood regulation, memory consolidation, and the capacity for new learning. Clinical studies consistently show that people with depression have reduced BDNF levels — what underlies "The BDNF-Depression Gap" — and that BDNF levels rise in response to effective treatment, whether that's therapy, antidepressants, or exercise.

A 2020 review of the antidepressant potential of Hericium erinaceus noted that its bioactive compounds rescue alterations in neurotransmitter and neuro-endocrine systems, stimulate neurogenesis and the synthesis of neurotrophic factors, and counteract oxidative stress and inflammation — mechanisms that overlap with conventional antidepressants (PMID: 32178272).

A landmark 2019 review in International Journal of Molecular Sciences proposed that lion's mane may represent a viable alternative approach to depression specifically because of its neurotrophic and neurogenic properties — noting that the traditional antidepressant assumption (purely a serotonin problem) is increasingly challenged by the neurotrophic hypothesis of depression (PMID: 31881712).

A 2026 review published in International Journal of Molecular Sciences advanced this framework further, proposing that hericenones and erinacines modulate key transcriptional hubs including CREB, Nrf2, and NF-κB, which regulate non-coding RNAs known to control neurogenesis, synaptogenesis, and neuroinflammation. The researchers described this as a potentially unexplored epigenetic axis explaining the pleiotropic neuroprotective effects of lion's mane compounds (PMID: 41683696).

"Bioactive ingredients found within Hericium erinaceus target the main biochemical events implicated in mental disorders, mimicking, to some extent, the mechanisms of conventional antidepressants and mood stabilisers with a wide margin of tolerability." — Limanaqi et al., Antioxidants, 2020 (PMID: 32178272)

What the Human Research Actually Shows

The most-cited human study is a 2010 randomised controlled trial involving 30 menopausal women in Japan. After four weeks of consuming Hericium erinaceus cookies at a dose equivalent to approximately 2 g daily, participants showed significantly reduced scores for depression and anxiety compared to the placebo group. The researchers attributed this to NGF-stimulating compounds — hericenones — rather than a direct neurotransmitter effect (PMID: 20834180).

A 2023 double-blind, parallel-group pilot study (n=41) examined both acute and chronic effects of lion's mane supplementation (1.8 g daily) on cognitive function, stress, and mood in young healthy adults. The chronic supplementation phase showed promising trends for mood improvement. The researchers noted that the pilot study size warranted larger confirmatory trials before drawing firm conclusions (PMID: 38004235).

A 2025 double-blind RCT in healthy younger adults found that a standardised Hericium erinaceus extract produced acute improvements in cognition and mood, providing evidence that the bioactive metabolites — erinacines and hericenones — have measurable neurological effects in humans at doses used in studies (PMID: 40276537).

A 2025 study examining both Ganoderma lucidum and Hericium erinaceus used a simulated gut environment to model how the mushrooms' compounds interact with human microbiota before reaching the brain. The research found that mushroom-derived metabolites upregulated BDNF, CDNF, and MANF — neurotrophic factors crucial for neuronal function — and activated the CREB/BDNF signalling pathway associated with mood enhancement via the gut-brain axis (PMID: 39848413).

A 2025 systematic review of edible and medicinal fungi as antidepressant candidates confirmed that Hericium erinaceus extracts demonstrate significant antidepressant-like effects in preclinical models, operating through the tryptophan-kynurenine pathway, regulation of the hypothalamus-pituitary-adrenal (HPA) axis, reduced neuroinflammation, and gut microbiota modulation (PMID: 40289452).

The Limitations — What We Don't Yet Know

Transparency is non-negotiable when discussing depression and natural approaches. Here is what the current evidence does not show — and these limitations are important.

Most studies were animal or in vitro models — not human trials. Human evidence is limited. The human trials that do exist are small (n=30 to n=41), short in duration (4–12 weeks), and not conducted in clinical depression populations. Extrapolating from these to people with diagnosed major depressive disorder requires significant caution.

• No large-scale RCTs specifically for major depressive disorder exist. The 2010 Nagano trial (PMID: 20834180) measured mood as a secondary outcome in menopausal women — not a clinically depressed population. Depression-specific trials with clinical populations are still needed.
• The 2023 pilot study (n=41) found no significant effect on depression scores as a primary outcome. The study did not improve depression measures to statistical significance. Mood improvements observed were exploratory findings requiring larger confirmatory trials — not demonstration of efficacy (PMID: 38004235).
• Animal models of anxiety showed mixed results. A 2021 mouse study showed lion's mane mycelium ameliorated sleep-disturbance-induced anxiety. However, this result did not demonstrate direct human applicability, and no difference between animal and human responses can be assumed (PMID: 34865649).
• No Cochrane systematic review exists for lion's mane and mood. The current evidence base is preliminary and has not undergone the most rigorous level of systematic analysis. Absence of a Cochrane review is a significant limitation for clinical credibility.
• EFSA and FSANZ have not approved health claims for lion's mane relating to mood or cognitive function in Australia or Europe. No formal health claim is permitted.
• Potential interactions with psychiatric medications have not been fully studied. This is not trivial — anyone on antidepressants, anxiolytics, or mood stabilisers should not add any supplement, including lion's mane, without consulting their prescriber.

A 2023 review tracking Hericium erinaceus in neurological research noted that clinical translation from bench to bedside remains in its early stages, and standardised dosing protocols for mood applications failed to demonstrate sufficient consistency across the available trials (PMID: 37233262). More research is needed before firm efficacy claims can be made.

The Gut-Brain Axis — An Emerging Angle

One dimension of lion's mane's mood-related research that deserves attention is its effect on the gut-brain axis.

The gut produces approximately 90% of the body's serotonin. The enteric nervous system — sometimes called the "second brain" — communicates bidirectionally with the central nervous system via the vagus nerve. Disruptions to the gut microbiome are increasingly associated with mood disorders.

Lion's mane contains beta-glucan polysaccharides that act as prebiotics, selectively feeding beneficial gut bacteria. The 2025 ex vivo study (PMID: 39848413) demonstrated that lion's mane metabolites, after passing through a simulated gut environment, upregulated key neurotrophic factors in neuronal cells — suggesting the mood-related effects may partly travel through the gut-microbiome-brain axis rather than purely through direct CNS action.

This is speculative in humans, and most evidence remains preclinical. But it adds a plausible secondary mechanism beyond the NGF/BDNF pathway — and may explain why consistent daily dosing (which keeps microbiome-modulating compounds in steady supply) appears more relevant than single-dose administration.

You can try combining lion's mane with other gut-supportive practices — pair with a diet rich in fermented foods, or stack with a quality probiotic alongside your lion's mane — to support this axis. This is not a studied combination, but the mechanistic logic is sound.

Should You Explore Lion's Mane for Mood?

How to Use Lion's Mane for Mood Support

If you have discussed it with your healthcare professional and want to try lion's mane as part of a broader mood support strategy:

• Dose: Clinical trials have used 750 mg to 3 g daily. You can start with 1 g (approximately half a teaspoon of extract powder) and assess over 2–4 weeks. The doses used in studies were consistent daily servings, not sporadic use.
• Timing: Morning is most common. The 2010 RCT used daily intake without specific time restrictions (PMID: 20834180).
• Duration: Aim for at least 4 weeks of consistent daily use before evaluating. The Nagano trial showed significant effects at the 4-week mark. Consider a 12-week trial period for a meaningful assessment of mood-related effects.
• Format: A dual-extracted fruiting body powder ensures both hericenones (ethanol-soluble) and beta-glucans (water-soluble) are present. Stir into tea, coffee, or warm water. Try combining with ashwagandha for broader adaptogenic support if you're also managing stress alongside mood concerns — though this combination has not been studied in clinical trials.
• Avoid if: You are pregnant, breastfeeding, or have a mushroom allergy. Not suitable as a replacement for prescribed treatment.

Our Formulation — What We Look For in Lion's Mane

Specification	Detail
Extraction Method	Dual extract (Ethanol & Water)
Concentration Ratio	10:1
Beta-glucan Specification	≥30%
Beta-glucan Actual (COA)	31.7%
Source	100% fruiting body, Di Tao sourced (China)
Certification	ACO Certified Organic

Frequently Asked Questions

Can lion's mane replace antidepressant medication?

No. Lion's mane should not be used as a replacement for prescribed medication. It may be explored as a complementary approach alongside professional treatment — always consult your healthcare professional before making any changes to your treatment plan.

How does lion's mane affect mood differently from SSRIs?

SSRIs primarily work by increasing serotonin availability. Lion's mane works through a different mechanism — supporting nerve growth factor (NGF) and BDNF production via its bioactive hericenones and erinacines. These are complementary, not competing, mechanisms. This is the core of "The Neurotrophic Cascade Effect". The two approaches are not interchangeable.

How long does lion's mane take to affect mood?

The 2010 Nagano trial showed significant reductions in depression and anxiety scores after 4 weeks of daily intake at doses used in studies (PMID: 20834180). Some acute mood effects have been observed within hours in more recent research (PMID: 40276537). Aim for at least 4 weeks of consistent daily use for a meaningful evaluation of mood-related effects.

Is lion's mane safe to take alongside anxiety medication?

Potential interactions with psychiatric medications — including anxiolytics — have not been fully studied. You should consult your prescribing healthcare professional before combining lion's mane with any medication. This is not a precaution to be skipped.

What dose of lion's mane is used for mood research?

Clinical trials have used doses ranging from 750 mg to 3 g daily. The 2010 RCT used doses equivalent to approximately 2 g daily. The 2023 pilot study used 1.8 g daily (PMID: 38004235). A reasonable starting point is 1 g daily (half a teaspoon of our extract powder), increasing to 2 g after two weeks if well tolerated.

Does lion's mane help with both depression and anxiety?

The 2010 trial found significant improvements in both depression and anxiety scores after four weeks of daily use (PMID: 20834180). The neurotrophic mechanism — supporting NGF and BDNF, reducing neuroinflammation — is biologically relevant to both conditions. However, no current evidence confirms lion's mane as an effective treatment for anxiety disorder or depressive disorder as standalone interventions.

Are there any side effects related to mood from lion's mane?

Clinical trials have reported a generally strong safety profile. No mood-specific adverse effects have been reported. Some individuals experience mild digestive discomfort when starting supplementation. If you experience any unusual mood changes after starting lion's mane, stop use and seek medical advice.

When is lion's mane not appropriate for mood support?

Lion's mane is not appropriate as a replacement for professional mental health treatment. It is not recommended if you are currently adjusting psychiatric medications without discussing it first with your prescriber. It is also unlikely to help as a standalone measure if foundational lifestyle factors — sleep, exercise, diet, social connection — are not addressed. For severe or treatment-resistant depression, professional care is essential and lion's mane is not an adequate intervention.

For more on lion's mane, explore our guides on lion's mane for anxiety, lion's mane for stress and cortisol, and lion's mane benefits overview.

Disclaimer: This article is for informational and educational purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Lion's mane is not a substitute for professional mental health treatment. Always consult your healthcare professional before starting any new supplement, especially if you are taking medications or have a diagnosed mental health condition.

---

Continue Your Research

• Lion's Mane Benefits: What 571 Studies Actually Show
• Lion's Mane for Anxiety: What the Research Actually Shows
• Lion's Mane for Stress: What the Research Shows About The Indirect Pathway
• Lion's Mane and Antidepressants: The Clinical Evidence
• Lion's Mane Dosage Guide: Clinical Trial Doses, Extract Conversions & Timing
• Lion's Mane Side Effects: Safety Profile Review
• Lion's Mane for ADHD and Focus: What the Research Actually Shows
• Lion's Mane for Gut Health: The Prebiotic Bridge Your Microbiome Has Been Waiting For

← Back to Lion's Mane Research Hub